Subzone Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in New Delhi, Delhi, India, established in 2018.
2018 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Subzone Pharmaceuticals Private Limited

Subzone Pharmaceuticals Private Limited, a active private limited company, was established on 20 July 2018 in New Delhi, Delhi, India. Engaging in specialty within the trading sector, it holds CIN: U51909DL2018PTC336828. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Jay Shankar Mishra (Director), Chandan Kumar Jha (Additional Director), Ranjeet Jha (Director). Past directors included Amrendra Kumar Jha. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 20, Kh. No. 1079, Ground Floor Prem Nagar-2, Blk-N, Suleman Nagar,, New Delhi, Delhi, 110086.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909DL2018PTC336828

  • Registration Number

    336828

  • Incorporation Date

    20 July 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 7 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 4.54%
  • Profit Growth **** -34.94%
  • Ebitda **** 38556.00%
  • Net Worth 0.19%
  • Total Assets **** 33.52%
Company report

Subzone Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Subzone Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Subzone Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Jay Shankar Mishra Director 20 Jul 2018 Current
Chandan Kumar Jha Additional Director 23 Sep 2022 Current
Ranjeet Jha Director 12 Jul 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Jul 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Subzone Pharmaceuticals.

Subzone Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.54% increase. The company also saw a substantial fall in profitability, with a 34.94% decrease in profit. The company's net worth moved up by a moderate rise of 0.19%.

Subzone Pharmaceuticals revenue growth over time
Subzone Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.54%
*******
*******
*******
*******
Revenue from Operations
*******
 4.54%
*******
*******
*******
*******
Total Assets
*******
 33.52%
*******
*******
*******
*******
Profit or Loss
*******
 -34.94%
*******
*******
*******
*******
Net Worth
*******
 0.19%
*******
*******
*******
*******
EBITDA
*******
 38556.00%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Subzone Pharmaceuticals?

Unlock access to Subzone Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Subzone Pharmaceuticals?

Unlock and access historical data on people associated with Subzone Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Subzone Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Subzone Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Subzone Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Subzone Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Subzone Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii. was completed.

  • Director Appointment

    Chandan Kumar Jha was appointed as a Additional Director was appointed as a Additional Director on 23 Sep 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.

  • Director Appointment

    Ranjeet Jha was appointed as a Director was appointed as a Director on 12 Jul 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Jay Shankar Mishra was appointed as a Director was appointed as a Director on 20 Jul 2018 & has been associated with this company since 7 years 8 months . was completed.

  • Company Incorporation

    Progress on Subzone Pharmaceuticals Private Limited was registered on 20 Jul 2018 with Roc Delhi Ii & aged 7 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Subzone Pharmaceuticals Private Limited?

The CIN of Subzone Pharmaceuticals Private Limited is U51909DL2018PTC336828.

Where is Subzone Pharmaceuticals Private Limited headquartered?

Subzone Pharmaceuticals Private Limited is headquartered at Plot No. 20, Kh. No. 1079, Ground Floor Prem Nagar-2, Blk-N, Suleman Nagar,, New Delhi, Delhi, 110086.

When was Subzone Pharmaceuticals Private Limited incorporated?

Subzone Pharmaceuticals Private Limited was incorporated on 20 July 2018.

Who are the current directors of Subzone Pharmaceuticals Private Limited?

The current directors of Subzone Pharmaceuticals Private Limited are

What is the primary industry of Subzone Pharmaceuticals Private Limited?

The primary industry of Subzone Pharmaceuticals Private Limited is Trading.

Is Subzone Pharmaceuticals Private Limited a listed company?

Subzone Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Subzone Pharmaceuticals Private Limited?

The authorized capital of Subzone Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available